Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02765165
Title Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Proximagen, LLC
Indications

Advanced Solid Tumor

glioblastoma

Therapies

Lomustine + USL311

USL311

Age Groups: senior | adult
Covered Countries USA | ESP


No variant requirements are available.